CLDN3 and obstructive sleep apnea syndrome: In addition, Urinary CLDN-3 was negative associated with the severity of OSA.<h4>Conclusion</h4>CLDN molecules are promising as useful biomarkers for OSA, which may be related to the impaired barrier function related to OSA.